These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 24185513)

  • 1. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.
    Chan-On W; Nairismägi ML; Ong CK; Lim WK; Dima S; Pairojkul C; Lim KH; McPherson JR; Cutcutache I; Heng HL; Ooi L; Chung A; Chow P; Cheow PC; Lee SY; Choo SP; Tan IB; Duda D; Nastase A; Myint SS; Wong BH; Gan A; Rajasegaran V; Ng CC; Nagarajan S; Jusakul A; Zhang S; Vohra P; Yu W; Huang D; Sithithaworn P; Yongvanit P; Wongkham S; Khuntikeo N; Bhudhisawasdi V; Popescu I; Rozen SG; Tan P; Teh BT
    Nat Genet; 2013 Dec; 45(12):1474-8. PubMed ID: 24185513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing of liver fluke-associated cholangiocarcinoma.
    Ong CK; Subimerb C; Pairojkul C; Wongkham S; Cutcutache I; Yu W; McPherson JR; Allen GE; Ng CC; Wong BH; Myint SS; Rajasegaran V; Heng HL; Gan A; Zang ZJ; Wu Y; Wu J; Lee MH; Huang D; Ong P; Chan-on W; Cao Y; Qian CN; Lim KH; Ooi A; Dykema K; Furge K; Kukongviriyapan V; Sripa B; Wongkham C; Yongvanit P; Futreal PA; Bhudhisawasdi V; Rozen S; Tan P; Teh BT
    Nat Genet; 2012 May; 44(6):690-3. PubMed ID: 22561520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.
    Jiao Y; Pawlik TM; Anders RA; Selaru FM; Streppel MM; Lucas DJ; Niknafs N; Guthrie VB; Maitra A; Argani P; Offerhaus GJA; Roa JC; Roberts LR; Gores GJ; Popescu I; Alexandrescu ST; Dima S; Fassan M; Simbolo M; Mafficini A; Capelli P; Lawlor RT; Ruzzenente A; Guglielmi A; Tortora G; de Braud F; Scarpa A; Jarnagin W; Klimstra D; Karchin R; Velculescu VE; Hruban RH; Vogelstein B; Kinzler KW; Papadopoulos N; Wood LD
    Nat Genet; 2013 Dec; 45(12):1470-1473. PubMed ID: 24185509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and transcriptional alterations of cholangiocarcinoma.
    Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Opisthorchis viverrini-related cholangiocarcinoma.
    Jusakul A; Kongpetch S; Teh BT
    Curr Opin Gastroenterol; 2015 May; 31(3):258-63. PubMed ID: 25693006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans.
    Nair SS; Bommana A; Pakala SB; Ohshiro K; Lyon AJ; Suttiprapa S; Periago MV; Laha T; Hotez PJ; Bethony JM; Sripa B; Brindley PJ; Kumar R
    Hepatology; 2011 Oct; 54(4):1388-97. PubMed ID: 21725997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.
    Ma B; Meng H; Tian Y; Wang Y; Song T; Zhang T; Wu Q; Cui Y; Li H; Zhang W; Li Q
    BMC Cancer; 2020 Apr; 20(1):318. PubMed ID: 32293336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters.
    Dechakhamphu S; Pinlaor S; Sitthithaworn P; Bartsch H; Yongvanit P
    Mutat Res; 2010 Sep; 691(1-2):9-16. PubMed ID: 20541562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
    Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
    Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?
    Bagante F; Ruzzenente A; Conci S; Rusev BC; Simbolo M; Campagnaro T; Pawlik TM; Luchini C; Iacono C; Scarpa A; Guglielmi A
    HPB (Oxford); 2019 Dec; 21(12):1648-1655. PubMed ID: 31122820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct antibody response in susceptible and non-susceptible hosts of the carcinogenic liver fluke
    Watakulsin K; Surapaitoon A; Ulag LH; Kaing S; Suyapoh W; Saichua P; Salao K; Tangkawatana S; Suttiprapa S
    Parasitology; 2023 Jul; 150(8):653-660. PubMed ID: 37288733
    [No Abstract]   [Full Text] [Related]  

  • 13. A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells.
    Smout MJ; Laha T; Mulvenna J; Sripa B; Suttiprapa S; Jones A; Brindley PJ; Loukas A
    PLoS Pathog; 2009 Oct; 5(10):e1000611. PubMed ID: 19816559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.
    Chusorn P; Namwat N; Loilome W; Techasen A; Pairojkul C; Khuntikeo N; Dechakhamphu A; Talabnin C; Chan-On W; Ong CK; Teh BT; Yongvanit P
    Tumour Biol; 2013 Jun; 34(3):1579-88. PubMed ID: 23417858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of liver fluke infection as risk factor for cholangiocarcinoma.
    Sithithaworn P; Yongvanit P; Duenngai K; Kiatsopit N; Pairojkul C
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):301-8. PubMed ID: 24408775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
    Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
    JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function association of enhanced expressed genes between Opisthorchis viverrini and non Opisthorchis viverrini-related cholangiocarcinoma.
    Wiwanitkit V
    Rev Esp Enferm Dig; 2008 Jul; 100(7):439-40. PubMed ID: 18808295
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma.
    Grassian AR; Pagliarini R; Chiang DY
    Curr Opin Gastroenterol; 2014 May; 30(3):295-302. PubMed ID: 24569570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opisthorchis viverrini: Gene expression profiling of carcinogenic adult liver fluke worms using 5' SAGE.
    Chutiwitoonchai N; Shen Y; Zheng H; Xiong H; Zhao G; Imtawil K; Intapan PM; Wongkham S; Wongkham C
    Exp Parasitol; 2008 Dec; 120(4):306-13. PubMed ID: 18786530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.